Pharmacists should recommend authorized generics for patients with inactive ingredient sensitivities, narrow therapeutic index drugs, or modified-release formulations. They offer brand-level safety at generic prices - but only if you know when and how to suggest them.
Contamination controls in generic drug manufacturing prevent harmful adulteration through strict cleanroom standards, real-time monitoring, and human process discipline - ensuring patient safety and regulatory compliance.
Evergreening lets drug companies extend patents on old medications with minor changes, blocking generics and keeping prices high. Learn how it works, who it hurts, and what’s being done to stop it.